Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Combination Pain Therapy in HIV Neuropathy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Duloxetine and Methadone for the Treatment of HIV-Associated Painful Peripheral Neuropathy
Status: Enrolling
Updated:  12/31/1969
MetroHealth CRS
mi
from
Cleveland, OH
Combination Pain Therapy in HIV Neuropathy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Duloxetine and Methadone for the Treatment of HIV-Associated Painful Peripheral Neuropathy
Status: Enrolling
Updated: 12/31/1969
MetroHealth CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Combination Pain Therapy in HIV Neuropathy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Duloxetine and Methadone for the Treatment of HIV-Associated Painful Peripheral Neuropathy
Status: Enrolling
Updated:  12/31/1969
Houston AIDS Research Team CRS
mi
from
Houston, TX
Combination Pain Therapy in HIV Neuropathy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Duloxetine and Methadone for the Treatment of HIV-Associated Painful Peripheral Neuropathy
Status: Enrolling
Updated: 12/31/1969
Houston AIDS Research Team CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Design of an Affordable Gym for Post Stroke Rehabilitation
Design of an Affordable Gym for Post Stroke Rehabilitation
Status: Enrolling
Updated:  12/31/1969
Penn Medicine Rittenhouse
mi
from
Philadelphia, PA
Design of an Affordable Gym for Post Stroke Rehabilitation
Design of an Affordable Gym for Post Stroke Rehabilitation
Status: Enrolling
Updated: 12/31/1969
Penn Medicine Rittenhouse
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 106
mi
from
Huntsville, AL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 106
mi
from
Huntsville, AL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 104
mi
from
Mobile, AL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 104
mi
from
Mobile, AL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 14
mi
from
Tucson, AZ
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 14
mi
from
Tucson, AZ
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 121
mi
from
Los Alamitos, CA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 121
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 17
mi
from
San Diego, CA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 17
mi
from
San Diego, CA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 36
mi
from
Denver, CO
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 36
mi
from
Denver, CO
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 125
mi
from
New London, CT
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 125
mi
from
New London, CT
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 07
mi
from
Washington,
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 07
mi
from
Washington,
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 120
mi
from
Coral Gables, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 120
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 99
mi
from
Fort Myers, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 99
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 54
mi
from
North Miami, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 54
mi
from
North Miami, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 114
mi
from
Saint Petersburg, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 114
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 80
mi
from
West Palm Beach, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 80
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 23
mi
from
Sandy Springs, GA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 23
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 91
mi
from
Savannah, GA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 91
mi
from
Savannah, GA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 55
mi
from
Wichita, KA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 55
mi
from
Wichita, KA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 88
mi
from
Lexington, KY
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 88
mi
from
Lexington, KY
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 86
mi
from
Louisville, KY
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 86
mi
from
Louisville, KY
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 103
mi
from
Boston, MA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 103
mi
from
Boston, MA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 81
mi
from
Plainsboro, NJ
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 81
mi
from
Plainsboro, NJ
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 58
mi
from
Raleigh, NC
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 58
mi
from
Raleigh, NC
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 115
mi
from
Fargo, ND
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 115
mi
from
Fargo, ND
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 05
mi
from
Cleveland, OH
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 05
mi
from
Cleveland, OH
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 15
mi
from
Columbus, OH
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 15
mi
from
Columbus, OH
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 75
mi
from
Philadelphia, PA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 75
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 127
mi
from
Bluffton, SC
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 127
mi
from
Bluffton, SC
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 126
mi
from
Mount Pleasant, SC
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 126
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 94
mi
from
Chattanooga, TN
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 94
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 82
mi
from
Houston, TX
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 82
mi
from
Houston, TX
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 76
mi
from
Seattle, WA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 76
mi
from
Seattle, WA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site #128
mi
from
Los Angeles, CA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site #128
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 95
mi
from
Bradenton, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 95
mi
from
Bradenton, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 60
mi
from
Lake Worth, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 60
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site #118
mi
from
Miami Lakes, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site #118
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 92
mi
from
Oviedo, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 92
mi
from
Oviedo, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 105
mi
from
Sanford, FL
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 105
mi
from
Sanford, FL
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 119
mi
from
Roswell, GA
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 119
mi
from
Roswell, GA
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 22
mi
from
Kalamazoo, MI
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 22
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 123
mi
from
Portsmouth, NH
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 123
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 101
mi
from
Berlin, NJ
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 101
mi
from
Berlin, NJ
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 19
mi
from
New York, NY
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 19
mi
from
New York, NY
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 110
mi
from
Poughkeepsie, NY
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 110
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 97
mi
from
Rochester, NY
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 97
mi
from
Rochester, NY
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 116
mi
from
Canton, OH
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 116
mi
from
Canton, OH
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site # 112
mi
from
Myrtle Beach, SC
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site # 112
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
EndoCeutics site # 64
mi
from
Jackson, TN
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
EndoCeutics site # 64
mi
from
Jackson, TN
Click here to add this to my saved trials
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated:  12/31/1969
Endoceutics site #124
mi
from
Knoxville, TN
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)
Status: Enrolling
Updated: 12/31/1969
Endoceutics site #124
mi
from
Knoxville, TN
Click here to add this to my saved trials